Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.

Abstract

BACKGROUND:

Ovarian cancer is one of the most common and malignant cancers, partly due to its late diagnosis and high recurrence. Chemotherapy resistance has been linked to poor prognosis and is believed to be linked to the cancer stem cell (CSC) pool. Therefore, elucidating the molecular mechanisms mediating therapy resistance is essential to finding new targets for therapy-resistant tumors.

METHODS:

shRNA depletion of MYPT1 in ovarian cancer cell lines, miRNA overexpression, RT-qPCR analysis, patient tumor samples, cell line- and tumorsphere-derived xenografts, in vitro and in vivo treatments, analysis of data from ovarian tumors in public transcriptomic patient databases and in-house patient cohorts.

RESULTS:

We show that MYPT1 (PPP1R12A), encoding myosin phosphatase target subunit 1, is downregulated in ovarian tumors, leading to reduced survival and increased tumorigenesis, as well as resistance to platinum-based therapy. Similarly, overexpression of miR-30b targeting MYPT1 results in enhanced CSC-like properties in ovarian tumor cells and is connected to the activation of the Hippo pathway. Inhibition of the Hippo pathway transcriptional co-activator YAP suppresses the resistance to platinum-based therapy induced by either low MYPT1 expression or miR-30b overexpression, both in vitro and in vivo.

CONCLUSIONS:

Our work provides a functional link between the resistance to chemotherapy in ovarian tumors and the increase in the CSC pool that results from the activation of the Hippo pathway target genes upon MYPT1 downregulation. Combination therapy with cisplatin and YAP inhibitors suppresses MYPT1-induced resistance, demonstrating the possibility of using this treatment in patients with low MYPT1 expression, who are likely to be resistant to platinum-based therapy.

• Authors: Sandra Muñoz-Galván, Blanca Felipe-Abrio, Eva M Verdugo-Sivianes, Marco Perez, Manuel P Jiménez-García, Elisa Suarez-Martinez, Purificacion Estevez-Garcia, Amancio Carnero
• Journal: Molecular cancer (Mol Cancer) Vol. 19 Issue 1 Pg. 7 (01 11 2020) ISSN: 1476-4598 [Electronic] England
• PMID: 31926547 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• Biomarkers, Tumor
• MIRN30b microRNA, human
• MicroRNAs
• Protein Serine-Threonine Kinases
• Cisplatin

Topics

• Animals
• Antineoplastic Agents (pharmacology)
• Apoptosis
• Biomarkers, Tumor (genetics, metabolism)
• Cell Proliferation
• Cisplatin (pharmacology)
• Drug Resistance, Neoplasm
• Female
• Gene Expression Regulation, Neoplastic
• Hippo Signaling Pathway
• Humans
• Mice
• Mice, Nude
• MicroRNAs (genetics)
• Neoplasm Invasiveness
• Neoplasm Recurrence, Local (drug therapy, metabolism, pathology)
• Neoplastic Stem Cells (drug effects, metabolism, pathology)
• Ovarian Neoplasms (drug therapy, metabolism, pathology)
• Prognosis
• Protein Serine-Threonine Kinases (genetics, metabolism)
• Signal Transduction
• Survival Rate
• Tumor Cells, Cultured
• Xenograft Model Antitumor Assays